logo

Innate Pharma S.A (IPHA)



Trade IPHA now with
  Date
  Headline
6/3/2022 1:07:42 AM Innate Pharma To Advance Into Phase 2 Clinical Trial In Lung Cancer
5/10/2022 1:06:16 AM Innate Pharma Q1 Revenues EUR 2.6 Mln Vs EUR 4.5 Mln Last Year
4/8/2022 1:05:51 AM Innate Pharma To Hold AGM Of Shareholders On May 20, 2022
3/24/2022 2:06:59 AM Innate Pharma FY Loss EUR 52.8 Mln Vs. Net Loss EUR 64.0 Mln Prior Year
1/5/2022 1:04:12 AM Innate Pharma Obtains EUR 28.7 Mln In Non-dilutive financing In Form Of Two Loans From Socit Gnrale And BNP Paribas
12/16/2021 1:05:28 AM Innate Pharma Says First Patient Dosed In IPH6101/SAR443579 Phase 1/2 Clinical Trial In Various Blood Cancers
12/2/2021 6:07:18 AM Innate Pharma To Present Monalizumab Data At ESMO Immuno-Oncology 2021 Congress
11/16/2021 1:05:15 AM Innate Pharma 9-month Revenues Decline To EUR 10.3 Mln From EUR 33.6 Mln Prior Year
9/15/2021 1:11:30 AM Innate Pharma H1 Net Loss EUR 23.7 Mln Vs Loss Of EUR 10.3 Mln Last Year
6/22/2021 7:20:17 AM Intema Signs LoI To Acquire Team BloodHounds Inc., Owner Of The Team BH Esports Team
6/22/2021 7:15:43 AM Innate Pharma Presents Preliminary Data From Mycosis Fungoides Cohort Of Phase 2 TELLOMAK Trial